Lutemax protects the eyes against blue light damage.
Lutein and the zeaxanthin isomers (RR-zeaxanthin and RS [meso]-zeaxanthin) are found in high concentration in the macula--a region of the eye that provides the highest visual acuity and is also exposed to high levels of blue light.
In a new study, Lutemax 2020 supplementation was shown to protect photoreceptors against blue light damage by mitigating oxidative and endoplasmic reticulum stress--a primary mechanism associated with photoreceptor damage and visual impairment.
Lutemax 2020 is a naturally-derived ingredient from marigold flowers best known for providing all three macular carotenoids--lutein and both zeaxanthin isomers (RR-zeaxanthin and RS [meso]-zeaxanthin.
Beyond this new research, Lutemax 2020 has demonstrated other vision health and performance benefits in multiple studies including LAMA (Lutein, Vision and Mental Acuity) I and II and B.L.U.E. (Blue Light User Exposure).
As potent antioxidants and filters of blue light, they play a critical role in preserving visual function, especially as exposure to blue light from a variety of sources has steadily increased. The protective qualities of the macular carotenoids are well established, however, the mechanisms by which they protect have not been well explored.
This study effectively shows for the first time that blue light causes damage to the retinal tissue by not only promoting oxidative stress, which has been reported earlier, but also increases stress in the endoplasmic reticulum.
"This study addresses the growing public health issue of blue light exposure across all age groups and along with our prior research further demonstrates the importance of consistent and adequate intake of these important nutrients for healthy vision," said a lead researcher, Jayant Deshpande.
"Public awareness of blue light and its effects on eye health are new but steadily growing and we are leading the research to understand how macular carotenoids protect the eyes in an effort to help preserve visual performance and fight age-related eye diseases," he added.
The study appears in Nutrients journal.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
